SARS-CoV-2 3CL protease (3CLpro) in complex with compound 9 (simnotrelvir, SIM0417, SSD8432)

NIAID Data Ecosystem2026-05-02 收录

抗新冠病毒药物研发

3CL蛋白酶抑制剂

数据链接：

https://www.rcsb.org/structure/8IGX 数据链接链接失效反馈

官方服务：

资源简介：

SARS-CoV-2 3CL protease (3CLpro) in complex with compound 9 (simnotrelvir, SIM0417, SSD8432)

创建时间：

2024-05-08

Discovery of the Clinical Candidate S‑892216: A Second-Generation of SARS-CoV‑2 3CL Protease Inhibitor for Treating COVID-19

COVID-19

3CL蛋白酶抑制剂

The coronavirus disease 2019 (COVID-19) pandemic crisis has been mitigated by worldwide efforts to develop vaccines and therapeutic drugs. However, there remains concern regarding public health and an

Figshare2025-07-05 更新30

Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 150 micromolar X77.

抗新冠病毒药物研发

蛋白酶抑制剂

Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 150 micromolar X77.

NIAID Data Ecosystem20

SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM137

抗新冠病毒药物研发

分子对接

SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM137

NIAID Data Ecosystem00

the complex of SARS-CoV2 3CL and NB1A2

新冠病毒药物靶点

3CL蛋白酶抑制剂

the complex of SARS-CoV2 3CL and NB1A2

NIAID Data Ecosystem30

Global 3CL Protease Inhibitor Market Insights, Size, and Forecast By Application (Antiviral Therapy, Research and Development, Diagnostic Tools, Clinical Trials), By Drug Formulation (Oral, Injectable, Topical), By End Use (Hospitals, Clinics, Research Institutions, Pharmaceutical Companies), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

抗病毒药物市场

3CL蛋白酶抑制剂

MAK Data Insights00

SARS-CoV-2 3CL protease (3CLpro) in complex with compound 9 (simnotrelvir, SIM0417, SSD8432)

资源简介：

相关数据集